AstraZeneca PLC
1459.00
27-December-24 10:29:41
15 minutes delayed
Stocks
+5.00
+0.34%
Today's range
1445.00 - 1459.50
ISIN
N/A
Source
NASD.OMX SE
-
AstraZeneca To Discontine STABILIZE-CKD, DIALIZE-Outcomes Trials Under CRYSTALIZE Programme
01 Dec 2023 01:39:09 By NASDAQ US Markets
-
AstraZeneca Launches Evinova Healthtech Business
20 Nov 2023 08:21:15 By NASDAQ US Markets
-
Pharma Stock Roundup: FDA Okays AZN's Capivasertib & MRK's Keytruda Expanded Use
17 Nov 2023 08:20:24 By NASDAQ Stocks
-
AstraZeneca: Truqap Plus Faslodex Approved In US For HR+ Breast Cancer
17 Nov 2023 02:04:07 By NASDAQ US Markets
-
Interesting AZN Put And Call Options For July 2024
16 Nov 2023 10:57:01 By NASDAQ Stocks
-
AstraZeneca : Phase III Trial Of Imfinzi + Chemoradiotherapy In Lung Cancer Fails To Meet Main Goal
14 Nov 2023 02:55:47 By NASDAQ US Markets
-
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
10 Nov 2023 08:14:44 By NASDAQ Stocks
-
AstraZeneca Plc (AZN) Q3 2023 Earnings Call Transcript
09 Nov 2023 17:26:41 By NASDAQ US Markets
-
AstraZeneca Paying Up To $2 Billion For Experimental Obesity Pill—As Weight Loss Drug Market Grows
09 Nov 2023 08:57:51 By Forbes - World
-
09 Nov 2023 05:19:20 By MarketWatch
-
09 Nov 2023 04:10:57 By MarketWatch
-
AstraZeneca Reaches Obesity Drug Deal; Imfinzi Combination Meets Main Goal In Liver Cancer Trial
09 Nov 2023 02:55:26 By NASDAQ US Markets
-
AstraZeneca Q3 Pre-tax Profit Climbs; Lifts FY Outlook
09 Nov 2023 02:28:56 By NASDAQ US Markets
-
US FTC disputes listing for more than 100 patents in FDA Orange Book
07 Nov 2023 12:01:35 By NASDAQ US Markets
-
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
06 Nov 2023 13:44:08 By NASDAQ Stocks
-
AstraZeneca : Canada Approves Ultomiris For Adults With Neuromyelitis Optica Spectrum Disorder
01 Nov 2023 06:46:39 By NASDAQ US Markets
-
Cellectis Announces Collaboration Agreement With AstraZeneca; To Receive Up To $245 Mln
01 Nov 2023 04:05:04 By NASDAQ US Markets
-
Here’s Why You Could Be Giving Yourself—Or Someone Else—A Flu Shot Next Year
24 Oct 2023 07:18:46 By Forbes - World
-
AstraZeneca : FDA Accepts For Review SBLA For Self-administration Of Flumist Quadrivalent
24 Oct 2023 06:49:37 By NASDAQ US Markets
-
AstraZeneca : Enhertu Approved In EU For Advanced Non-small Cell Lung Cancer Treatment
23 Oct 2023 02:05:09 By NASDAQ US Markets